Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04891510 · ClinicalTrials.gov registry record · NA

A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery

A NA study of Breast Reconstruction and Mastectomy, sponsored by Weill Medical College of Cornell University.

Recruiting
Registry status
NA
Development phase
135
Enrollment target
1
Study location

NCT04891510 is a NA study of Breast Reconstruction and Mastectomy that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 135 participants, below the 386-participant average among 18 other Breast Reconstruction trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04891510, a NA study of Breast Reconstruction and Mastectomy, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.

RECRUITING
Registry status
NA
Development phase
135 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to learn whether there is a superior fat processing method in terms of graft retention in breast reconstruction after mastectomy.

Interventions

  • DEVICE REVOLVE Advanced Adipose System
  • DEVICE LipoGrafter
  • PROCEDURE Viality

Study Locations (1)

New York

  • New York Presbyterian - Weill Cornell Medicine - New York

Trial Details

FieldValue
Enrollment Target 135 participants
Start Date 2021-05-19
Est. Completion 2027-01
Phase NA

What the Registry Record Tells You About NCT04891510

The ClinicalTrials.gov registry entry for NCT04891510 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 135 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 386-participant average among 18 other Breast Reconstruction trials with a reported enrollment target (65% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Breast Reconstruction appearing as the primary indexed condition, and to 3 interventions - of which REVOLVE Advanced Adipose System is the first listed.

NCT04891510 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04891510 about?

NCT04891510 is a clinical study titled "A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery". The purpose of this study is to learn whether there is a superior fat processing method in terms of graft retention in breast reconstruction after mastectomy.

What is the current status of trial NCT04891510?

This trial is currently recruiting. It is a NA study. The enrollment target is 135 participants. The study started on 2021-05-19. Estimated completion is 2027-01.

What conditions does trial NCT04891510 study?

This clinical trial studies the following conditions: Breast Reconstruction, Mastectomy, Mammaplasty.

What interventions are being tested in trial NCT04891510?

The interventions under investigation include: REVOLVE Advanced Adipose System (DEVICE), LipoGrafter (DEVICE), Viality (PROCEDURE).

Who is sponsoring clinical trial NCT04891510?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04891510 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Reconstruction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.